Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03896503
Title Topotecan With or Without M6620 in Treating Patients With Relapsed Small Cell Lung Cancer or Extrapulmonary Small Cell Cancer
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

urinary bladder small cell neuroendocrine carcinoma

lung small cell carcinoma

prostate small cell carcinoma

Therapies

Topotecan

Berzosertib + Topotecan

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.